# Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)

> **NCT00940797** · PHASE2 · COMPLETED · sponsor: **Laboratorios Silanes S.A. de C.V.** · enrollment: 20 (actual)

## Conditions studied

- Diabetes Type 2

## Interventions

- **DRUG:** DMMET-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00940797
- **Lead sponsor:** Laboratorios Silanes S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-02
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940797, "Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00940797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*